Comparative Safety and Effectiveness of Loading Doses of P2Y12 Inhibitors in Patients Undergoing Elective PCI: a Network Meta-analysis.
Rahul GuptaAaqib H MalikAlexandros BriasoulisAmogh M JoshiDesire G GuthierTarun PopliWilbert S AronowApurva V VyasNainesh C PatelHasan AhmadBryan KluckPublished in: Cardiovascular drugs and therapy (2021)
Although prasugrel and ticagrelor are known as more potent antiplatelet agents, their effects in preventing MI and stroke are marginal and do not translate into improved overall mortality and bleeding compared with clopidogrel.
Keyphrases
- percutaneous coronary intervention
- patients undergoing
- atrial fibrillation
- acute coronary syndrome
- antiplatelet therapy
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- acute myocardial infarction
- coronary artery disease
- coronary artery bypass grafting
- randomized controlled trial
- cardiovascular events
- systematic review
- coronary artery bypass
- heart failure
- cardiovascular disease
- type diabetes
- anti inflammatory